Stay updated on Pembrolizumab/Gemcitabine in ABC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Gemcitabine in ABC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:35:38.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:51:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer’s displayed site revision advances from v3.7.0 to v3.7.1 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T13:56:10.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study record content. This blocks access to the NCT03025880 trial details on ClinicalTrials.gov.
    Difference
    21%
    Check dated 2026-09-20T19:42:58.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Adds 2016 (U.S. NIH Grant/Contract) to the study identifiers and updates the page revision to v3.6.6, while the previous v3.6.5 revision is deleted.
    Difference
    0.1%
    Check dated 2026-08-30T05:47:19.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.4 to v3.6.5, indicating a new internal version for the page with no visible content changes.
    Difference
    0.0%
    Check dated 2026-08-08T23:21:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Gemcitabine in ABC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.